[ Price : $8.95]
FDA says it has identified serious liver injuries in patients without cirrhosis of the liver being treated for primary biliary cho...[ Price : $8.95]
Keros Therapeutics stops some dosing in a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy i...[ Price : $8.95]
A detailed ProPublica investigative report says FDA failed to inspect a Glenmark Pharmaceuticals facility in India that had multip...[ Price : $8.95]
In a Time interview, president-elect Donald Trump said it has always been his commitment to preserve access to abortion pills, but...[ Price : $8.95]
The Association for Accessible Medicines urges Congress to pass pending legislation to allow FDA to disclose sameness information ...[ Price : $8.95]
FDA launches the CDER Center for Real-World Evidence Innovation with four areas of initial focus.[ Price : $8.95]
An IQVIA analysis of novel active substance approvals from 2014 to 2022 in the U.S., EU, and Japan shows the U.S. approves more ne...[ Price : $8.95]
FDA approves a Johnson & Johnson MedTech PMA supplement for expanded indications for the Impella 5.5 with SmartAssist and Impella ...